What Mustang Bio Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 0 | 2 |
| Total trades | 0 | 5 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 19 |
| Net activity | +0 | −19 |
Common stock only — 4 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Litchman Manuel Md | President, CEO and Interim CFO | Apr 24 | Withheld — tax / exercise cost · F | −19 | $0.75 | −$14.3 | 1,615 |
| Coronado Biosciences Inc | 10% owner | Jan 02 | Grant / award · A | +278,385 | — | — | 536,577 |
| Herskowitz Neil | Director | Dec 30 | Open-market sale · S | −247 | $0.96 | −$238 | 145 |
| Jin David | Director | Dec 30 | Open-market buy · P | +247 | $0.96 | +$238 | 286 |
| Chill Adam J. | Director | Dec 30 | Open-market sale · S | −4 | $0.95 | −$3.82 | 375 |
| Coronado Biosciences Inc | 10% owner | Sep 29 | Grant / award · A | +59,334 | — | — | 258,192 |
| Litchman Manuel Md | President, CEO and Interim CFO | Apr 24 | Withheld — tax / exercise cost · F | −27 | $1.24 | −$33.5 | 1,634 |
| Coronado Biosciences Inc | 10% owner | Mar 31 | Grant / award · A | +67,806 | — | — | 198,858 |
| Coronado Biosciences Inc | 10% owner | Jun 27 | Grant / award · A | +575,191 | — | — | 2,502,991 |
| Litchman Manuel Md | President and CEO | May 31 | Withheld — tax / exercise cost · F | −1,396 | $0.35 | −$489 | 83,024 |
| Coronado Biosciences Inc | 10% owner | Jan 02 | Grant / award · A | +419,092 | — | — | 1,927,800 |
| Rosenwald Lindsay A Md | Director | Jul 05 | Grant / award · A | +7,246 | — | — | 60,525 |
| Herskowitz Neil | Director | Jul 05 | Grant / award · A | +7,246 | — | — | 19,703 |
| Chill Adam J. | Director | Jul 05 | Grant / award · A | +7,246 | — | — | 19,170 |
| Zelefsky Michael J | Director | Jul 05 | Grant / award · A | +7,246 | — | — | 18,970 |
| Weiss Michael S | Director | Jul 05 | Grant / award · A | +7,246 | — | — | 49,637 |
| Litchman Manuel Md | President and CEO | Apr 24 | Withheld — tax / exercise cost · F | −1,572 | $4.21 | −$6.62K | 79,420 |
| Litchman Manuel Md | President and CEO | Apr 24 | Grant / award · A | +5,000 | — | — | 111,079 |
| Coronado Biosciences Inc | 10% owner | Jan 06 | Grant / award · A | +2,807,008 | — | — | 22,630,620 |
| Rosenwald Lindsay A Md | Director | Sep 13 | Open-market buy · P | +5,000 | $0.52 | +$2.58K | 299,181 |
Loading...
